Timeline

Nader Yatim

Physician

06 May 2024

publication

Sarcoidosis immunopathogenesis – a new concept of maladaptive trained immunity

25 Nov 2022

publication

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

01 Dec 2021

publication

Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

17 Nov 2021

publication

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.

01 Sep 2021

publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

18 Aug 2021

news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

01 Aug 2021

publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

17 Jul 2021

publication

Platelet activation in critically ill COVID-19 patients.

04 Jun 2021

publication

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.

13 Jul 2020

publication

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

27 May 2020

publication

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

10 May 2018

publication

Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes

13 Mar 2017

publication

Dying cells actively regulate adaptive immune responses

24 Sep 2015

publication

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells

15 Jun 2015

publication

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

06 Jun 2014

publication

RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis

21 Nov 2013

publication

Widespread mitochondrial depletion via mitophagy does not compromise necroptosis

28 Oct 2011

publication

A little guide for advanced search:

Timeline

Sarcoidosis immunopathogenesis – a new concept of maladaptive trained immunity

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Platelet activation in critically ill COVID-19 patients.

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes

Dying cells actively regulate adaptive immune responses

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis

Widespread mitochondrial depletion via mitophagy does not compromise necroptosis

Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity